Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05796791 · ClinicalTrials.gov registry record · Early Phase 1
Ketamine and Motivational Enhancement Therapy for the Treatment of Tobacco Use Disorder
A Early Phase 1 study of Smoking Cessation and Tobacco Use, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 7
- Enrollment target
- 1
- Study location
NCT05796791: Completed Early Phase 1 study of Smoking Cessation and Tobacco Use, sponsored by Medical University of South Carolina.
NCT05796791 is a Early Phase 1 study of Smoking Cessation and Tobacco Use that has completed, run by Medical University of South Carolina. The registered enrollment target is 7 participants, below the 475-participant average among 188 other Smoking Cessation trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05796791, a Early Phase 1 study of Smoking Cessation and Tobacco Use, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 7 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to examine whether an investigational medication called ketamine is able to improve treatment outcomes for tobacco use disorder when delivered in conjunction with brief motivational enhancement therapy. Participants will receive ketamine assisted motivational enhancement therapy weekly for three weeks and there will be 2 follow up visits. All visits will also consist of questionnaires and saliva samples will be taken. The overall participation will last approximately 8 weeks.
Primary Outcome
The primary outcome of this study will be the feasibility of using ketamine-assisted treatment for smoking cessation, which will assess the number of people selected for randomization that complete the full treatment. This will help determine if the treatment of ketamine in tobacco use would be beneficial for further study.
Conditions Studied
Interventions
- DRUG Ketamine Hydrochloride
- BEHAVIORAL Motivational enhancement therapy
Study Locations (1)
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2023-05-02 |
| Est. Completion | 2024-06-30 |
| Phase | Early Phase 1 |
What the finished NCT05796791 record still lists
NCT05796791 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 475-participant average among 188 other Smoking Cessation trials with a reported enrollment target (99% lower).
The record links to 3 conditions, with Smoking Cessation appearing as the primary indexed condition, and to 2 interventions - of which Ketamine Hydrochloride is the first listed.
NCT05796791 reports a single indexed study location in South Carolina.
Frequently Asked Questions
What is clinical trial NCT05796791 about?
NCT05796791 is a clinical study titled "Ketamine and Motivational Enhancement Therapy for the Treatment of Tobacco Use Disorder". The purpose of the study is to examine whether an investigational medication called ketamine is able to improve treatment outcomes for tobacco use disorder when delivered in conjunction with brief motivational enhancement therapy. Participants will receive ketamine assisted motivational enhancement ...
What is the current status of trial NCT05796791?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 7 participants. The study started on 2023-05-02. Estimated completion is 2024-06-30.
What conditions does trial NCT05796791 study?
This clinical trial studies the following conditions: Smoking Cessation, Tobacco Use, Nicotine Dependence.
What interventions are being tested in trial NCT05796791?
The interventions under investigation include: Ketamine Hydrochloride (DRUG), Motivational enhancement therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT05796791?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05796791 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05796791's enrollment target sits among peer trials
7 189th of 188 the lowest of 188 other Smoking Cessation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Smoking Cessation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Smoking Cessation Intervention During Low Dose CT (LDCT) Screening for Lung Cancer
ACTIVE NOT RECRUITING · Early Phase 1
-
Smoking Cessation Treatment for Head & Neck Cancer Patients
ACTIVE NOT RECRUITING · Early Phase 1
-
End Nicotine Dependence Clinic
COMPLETED · Early Phase 1
-
Hollings Cancer Center Varenicline Sampling Study
COMPLETED · Early Phase 1
-
Applying mHealth to Tobacco-related Health Disparities
COMPLETED · Early Phase 1
-
Smoking by IV Pulsed Nicotine
COMPLETED · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI